| SAVA Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SAVA shares outstanding history going back to 10/26/2018:
Also see: SAVA Market Cap History SAVA YTD Return |
SAVA Shares Outstanding History — Cassava Sciences Share Count Over Time
As of 3/9/2026 Cassava Sciences has 48.31 million SAVA shares outstanding. Investors often track the SAVA shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows SAVA share count trends over time, with 30 historical shares outstanding datapoints presented, dating back to 10/26/2018.
| SAVA Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SAVA Historical Shares Outstanding: +15.02% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SAVA Stock Price Chart |
| About Cassava Sciences Inc |
| Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. Co.'s science is based on stabilizing, but not removing, a critical protein in the Alzheimer's brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer's disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer's brain. We show 30 historical shares outstanding datapoints in our coverage of SAVA's shares outstanding history. Understanding the changing numbers of SAVA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SAVA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SAVA by allowing them to research SAVA shares outstanding history as well as any other stock in our coverage universe. |
| SAVA Current Stock Quote |
Quotes delayed 20 minutes  Free SAVA Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| SAVA Share Performance |
| Shares Outstanding Peers |
| Cassava Sciences (SAVA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SBFM Shares Outstanding History SBPH Shares Outstanding History SBTX Shares Outstanding History SCPH Shares Outstanding History SCPS Shares Outstanding History SCTL Shares Outstanding History SCYX Shares Outstanding History SDC Shares Outstanding History SDGR Shares Outstanding History SEEL Shares Outstanding History More Healthcare companies » |
SAVA Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
